Related Experiment Video
Updated: May 23, 2026

05:31
Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
Published on: January 26, 2024
[Insulin resistance in preeclampsia]
Summary
Preeclampsia is linked to insulin resistance, sharing common features like hypertension and obesity. Women with preeclampsia exhibit greater insulin resistance compared to normal pregnancies, with altered surrogate markers.
Area of Science:
- Reproductive Endocrinology
- Metabolic Disorders
- Maternal-Fetal Medicine
Context:
- Preeclampsia is a pregnancy-specific hypertensive disorder.
- Insulin resistance syndrome shares clinical features with preeclampsia.
- Understanding the link between metabolic health and pregnancy complications is crucial.
Purpose:
- To investigate the relationship between insulin resistance and preeclampsia.
- To compare insulin resistance levels in women with and without preeclampsia.
- To examine changes in surrogate markers of insulin resistance in preeclampsia.
Summary:
- Contemporary data reveal a significant association between insulin resistance and preeclampsia.
- Women with preeclampsia demonstrate heightened insulin resistance compared to those with normal pregnancies.
- Key features of insulin resistance syndrome, including hypertension, hyperinsulinemia, glucose intolerance, obesity, and lipid abnormalities, are prevalent in preeclampsia.
- Altered levels of surrogate markers for insulin resistance, such as leptin, TNF-alpha, tissue plasminogen activator, and SHBG, are observed in preeclampsia.
- The precise role of these metabolic alterations in the etiology or pathogenesis of preeclampsia remains an open question.
Impact:
- Highlights the metabolic underpinnings of preeclampsia.
- Suggests potential targets for future research and clinical interventions.
- Emphasizes the importance of considering maternal metabolic health in pregnancy outcomes.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...

